A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy
-
Aron Berkovsky
Abstract
Background: Oral anticoagulant therapy is monitored by a prothrombin time (PT) assay. The PT is standardised by the International Normalised Ratio (INR). The purpose of this study was to work out a modified method of PT/INR measurement in capillary blood for monitoring anticoagulation treatment.
Methods: Healthy donors, subjects with high or low haematocrit values, and oral anticoagulant-treated patients were included in the study. Plasma and capillary blood PT/INRs were determined by the standard Quick clotting assay, by the modified approach and with the CoaguChek S analyser.
Results: The performance characteristics of the developed method were accuracy, due to taking into account whole capillary blood haematocrit values, and precision, due to a decrease in the viscosity of the analysed samples. Implementation of the modified method showed that it is possible to use PT values of normal plasma for capillary blood INR calculation. The developed method allowed the determination of PT in capillary blood within the haematocrit value range from 0.15 up to 0.7. For capillary blood, the results of the modified method closely correlated with PT/INR values determined by the reference Quick method in venous plasma (r=0.99) and with the CoaguChek S analyser (r=0.97).
Conclusions: The modified method of capillary blood PT/INR determination could be recommended for oral anticoagulant therapy monitoring.
Clin Chem Lab Med 2006;44:1214–7.
References
1. Quick AJ. The prothrombin time in hemophilia and in obstructive jaundice. J Biol Chem 1935; 109:73–9.Search in Google Scholar
2. WHO Expert Committee on Biological Standardization. World Health Org Tech Rep Series 1999;889:64–93.Search in Google Scholar
3. Boehlen F, Reber G, de Moerloose P. Agreement of a new whole-blood PT/INR test using capillary samples with plasma. Thromb Res 2005; 115:131–4.10.1016/j.thromres.2004.06.023Search in Google Scholar
4. Burri S, Demarmels Biasiutti F, Lammle B, Wuillemin WA. [Comparison of Quick/INR values of whole capillary blood and venous citrate plasma in patients with and withoutoral anticoagulation.] Schweiz Med Wochenschr 1998; 44:1723–9, in German.Search in Google Scholar
5. Bamford E, Bowen RH, Broad JP, Hawken A, Morgan J, Owen CL, et al. A capillary whole blood method for measuring the INR. Clin Lab Haematol 2000; 22:279–85.10.1046/j.1365-2257.2000.00331.xSearch in Google Scholar
6. de Miguel D, Burgaleta C, Reyes E, Pascual T. Capillary whole blood testing by a new portable monitor. Comparison with standard determination of the international normalized ratio. Am J Clin Pathol 2003; 120:28–33.10.1309/604P8D3J7Q3GAADRSearch in Google Scholar
7. Woods K, Douketis JD, Schnurr T, Kinnon K, Powers P, Crowther MA. Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic. Thromb Res 2004; 114:161–5.10.1016/j.thromres.2004.05.013Search in Google Scholar
8. Ruseva A, Ivanov B, Petkova B. Possibility for determination of PT in peripheric blood. Med Pregl 2005; 41:94–6.Search in Google Scholar
9. Lucas FV, Duncan A, Jay R, Coleman R, Craft P, Chan B, et al. A novel whole blood capillary technique for measuring prothrombin time. Am J Clin Pathol 1987; 88:442–6.10.1093/ajcp/88.4.442Search in Google Scholar
10. Bland BD, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet 1986;307–10.10.1016/S0140-6736(86)90837-8Search in Google Scholar
11. Orellana MA, Martines P, Sanchez MT, Aramendi V, Galera G. Evaluation of the results obtained by the CoaguCheck S coagulometer in the control on the oral anticoagulant treatment. Med Clin (Barc) 2003; 1212:134–6.10.1016/S0025-7753(03)73881-0Search in Google Scholar
12. Jonsson M, Hillarp A, Svensson P. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy. Thromb Res 2004; 114:83–9.10.1016/j.thromres.2004.04.010Search in Google Scholar PubMed
13. Khoschnewis S, Hannes FM, Tschopp M, Wuillemin WA. INR comparison between the CoaguChek Pro PT (N) and a standard laboratory method. Thromb Res 2004; 113:327–32.10.1016/j.thromres.2004.03.021Search in Google Scholar PubMed
14. Yang DT, Robetorye RS, Rodgers GM. Home prothrombin time monitoring: a literature analysis. Am J Hematol 2004; 77:177–86.10.1002/ajh.20161Search in Google Scholar PubMed
15. Introcaso G, Cuboni A, Ratto A, Foieni F. Mathematical derivative applied to the International Normalized Ratio and analytical variations in the oral anticoagulant therapy control. Haemostasis 2000; 30:281–9.Search in Google Scholar
16. Macik BG, Rand JH, Konkle BA. Thrombophilia: what's a practitioner to do? Hematol Am Soc Hematol Educ Program 2001;322–338.10.1182/asheducation-2001.1.322Search in Google Scholar
17. Plesch W, Klimpel P. Performance evaluation of the CoaguChek S system. Haematology 2002; 87:557–9.Search in Google Scholar
18. Cosmi B, Palareti G, Moia M, Carpenedo M, Pengo V, Biasiolo A, et al. Accuracy of a portable prothrombin time monitor (CoaguChek) in patients on chronic oral anticoagulant therapy: a prospective multicenter study. Thromb Res 2000; 100:279–86.10.1016/S0049-3848(00)00323-6Search in Google Scholar
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Multiplexed testing in the autoimmunity laboratory
- Uncertainty calculation for calibrators and controls of laboratory diagnostic assays
- Westgard multirule for calculated laboratory tests
- Frequency of a single nucleotide (A2317G) and 56-bp variable number of tandem repeat polymorphisms within the deoxyribonuclease I gene in five ethnic populations
- The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function
- Apolipoprotein B gene 3′VNTR polymorphism: association with plasma lipids and coronary heart disease in Han Chinese
- Paraoxonase-1 (PON1) activity, but not PON1Q192R phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population
- A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy
- Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis
- Lipid peroxidation and antioxidative status in β-thalassemia major patients with or without hepatitis C virus infection
- Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males
- Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum
- Effect of nitrogen mustard, a vesicant agent, on lymphocyte energy metabolism
- Partitioning reference values of several Gaussian subpopulations with unequal prevalence – a procedure with computer program support
- Biovariability of plasma adiponectin
- Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood
- Innotrac Aio!: a point-of-care or a routine analyzer? Analytical performance and plasma/whole blood comparison
- Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing
- The importance of metrological traceability on the validity of creatinine measurement as an index of renal function: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
- Effect of seropositive rheumatoid factor on cardiac troponin I measurement using the Access® Immunoassay Analyzer
Articles in the same Issue
- Multiplexed testing in the autoimmunity laboratory
- Uncertainty calculation for calibrators and controls of laboratory diagnostic assays
- Westgard multirule for calculated laboratory tests
- Frequency of a single nucleotide (A2317G) and 56-bp variable number of tandem repeat polymorphisms within the deoxyribonuclease I gene in five ethnic populations
- The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function
- Apolipoprotein B gene 3′VNTR polymorphism: association with plasma lipids and coronary heart disease in Han Chinese
- Paraoxonase-1 (PON1) activity, but not PON1Q192R phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population
- A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy
- Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis
- Lipid peroxidation and antioxidative status in β-thalassemia major patients with or without hepatitis C virus infection
- Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males
- Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum
- Effect of nitrogen mustard, a vesicant agent, on lymphocyte energy metabolism
- Partitioning reference values of several Gaussian subpopulations with unequal prevalence – a procedure with computer program support
- Biovariability of plasma adiponectin
- Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood
- Innotrac Aio!: a point-of-care or a routine analyzer? Analytical performance and plasma/whole blood comparison
- Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing
- The importance of metrological traceability on the validity of creatinine measurement as an index of renal function: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
- Effect of seropositive rheumatoid factor on cardiac troponin I measurement using the Access® Immunoassay Analyzer
